radionuclide labeling process for murine or human monoclonal or polyclonal anti-tumor necrosis factor-associated antibodies to diseases whose pathophysiology involves tumor necrosis factor; 'in vivo' and / or 'in vitro' diagnostic reagent based on murine or human, monoclonal or polyclonal anti-tumor necrosis factor-associated antibodies to radionuclides; 'In vitro' and / or 'in vivo' diagnostic methods for diseases whose pathophysiology involves tumor necrosis factor using the reagent thus obtained and a kit for the diagnosis of diseases whose pathophysiology involves tumor necrosis factor based on said reagent

摘要

MARKING PROCESS WITH RADIONUCLIDS OF MURINE OR HUMAN, MONOCLONAL OR POLYCONAL ANTI-FACTOR OF TUMOR NECROSIS DISEASES ASSOCIATED WITH DISEASES WHOSE TUMOR NECROSIS FACTOR; REAGENT FOR "IN VIVO" AND / OR "IN VITRO" DIAGNOSIS BASED ON RADIONUCLIDE-RELATED ANTI-FACTOR OR HUMAN, HUMAN, HUMAN, OR POLYCLONAL ANTI-FACTOR ANTIBODIES; "IN VITRO" AND / OR "IN VIVO" DIAGNOSTIC DIAGNOSIS METHODS OF WHICH PHYSIOPATHOGENIA INVOLVES TUMORAL NECROSIS FACTOR USING THE REAGENT AS OBTAINED AND KIA FOR DISEASE DIAGNOSIS DEVELOPMENT OF THE FISIOPATHY. The present invention relates to a radionuclide labeling process for murine or human, monoclonal or polyclonal anti-tumor necrosis factor antibodies, as well as to the in vivo or in vitro diagnostic reagent based on anti-cancer antibodies. murine or human radionuclide-labeled monoclonal or polyclonal tumor necrosis factor, their use for diagnosis, the in vitro and in vivo diagnostic method of diseases whose pathophysiology involves the tumor necrosis factor and the diagnostic kit of immunological diseases using said reagent.